Introduction

Mainak Mazumdar ()
Additional contact information
Mainak Mazumdar: Centre De Sciences Humaines (CSH)

Chapter Chapter 1 in Performance of Pharmaceutical Companies in India, 2013, pp 1-15 from Springer

Abstract: Abstract This chapter presents an overview of the Indian Pharmaceutical Industry and traces its evolution and growth. From the review of policies and the analysis of the aggregate data, we conclude that the patent law of 1970 and the knowl-edge spillover from the public sector units provided the necessary impetus for the growth of the industry. Presently, the structure of industry looks highly competi-tive with the top twenty firms capturing about eighty percent of the market and negligible barrier to entry. However, contrary to the conventional economic wis-dom evidence also suggests that it is one of the most profitable industries. The co-existence of low concentration and high profit earning that is observed can be attributed to firm specific factors like its efficiency, returns from R&D, marketing related outlays and earning from global market.

Keywords: Foreign Direct Investment; Foreign Firm; Intellectual Property Right; Technological Frontier; Malmquist Productivity Index (search for similar items in EconPapers)
Date: 2013
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:conchp:978-3-7908-2876-4_1

Ordering information: This item can be ordered from
http://www.springer.com/9783790828764

DOI: 10.1007/978-3-7908-2876-4_1

Access Statistics for this chapter

More chapters in Contributions to Economics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().